수의 진단 시장 - 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of veterinary diagnostics Market

The global veterinary diagnostics market is witnessing substantial growth due to the rising prevalence of animal diseases, increasing pet ownership, and enhanced government initiatives to curb zoonotic outbreaks. Veterinary diagnostics involve tests performed on blood, tissue, urine, or stool to detect diseases, antibodies, proteins, or overall health indicators in animals. With the growing adoption of companion and livestock animals, as well as the demand for early detection of diseases, the market is set to expand significantly.

According to Fortune Business Insights, the market was valued at USD 8.78 billion in 2025, expected to grow to USD 9.72 billion in 2026, and projected to reach USD 21.59 billion by 2034, exhibiting a CAGR of 10.50% from 2026 to 2034. North America dominated the market in 2025 with a 47.82% share, driven by high pet ownership, increased expenditure on animal healthcare, favorable reimbursement policies, and strategic expansions by leading players. The U.S. market is projected to reach USD 6.96 billion by 2032, supported by robust investments in veterinary services and laboratory infrastructure.

Market Drivers

Rising Prevalence of Veterinary Diseases: Growing outbreaks of livestock and companion animal diseases, including zoonotic conditions like West Nile virus, influenza, coronaviruses, salmonella, rabies, and Lyme disease, are driving demand for diagnostic solutions. Molecular and immunodiagnostic tests are increasingly used to detect complex conditions, thereby supporting market expansion.

Growing Pet Ownership and Spending on Pet Care: Pet adoption is increasing globally, particularly in nuclear families. In the U.S., 66.0% of households owned a pet in 2024. Owners are investing more in preventive and diagnostic care, further propelling market growth. Initiatives such as mobile diagnostic services, like PepiPets in August 2022, allow in-home testing, enhancing accessibility and adoption.

Government Support and Awareness Campaigns: Strategic government funding and grants enhance early detection capabilities. For example, in November 2023, the Michigan State University Veterinary Diagnostic Laboratory received USDA funding to strengthen early detection of emerging animal diseases in the Midwest region. Such initiatives support market growth across North America and globally.

Market Restraints

Shortage of Skilled Veterinary Professionals: The scarcity of trained and qualified veterinarians limits the adoption of advanced diagnostic technologies, particularly in emerging markets. Studies indicate that approximately 41,000 veterinarians will be needed in the U.S. by 2030 to meet pet care demands. Additionally, inadequate training and insufficient laboratory staff hinder testing efficiency, restricting market expansion.

Market Segmentation

By Product Type:

• Reagents & Consumables: Dominates with a 76.69% share in 2026, fueled by frequent veterinary testing and increased spending on diagnostic kits.
• Instruments: Exhibits moderate CAGR, driven by growing veterinary hospitals and research initiatives.

By Technique:

• Immunodiagnostics: Leading segment with 25.33% market share in 2026, widely used for detecting critical animal diseases.
• Molecular Diagnostics: Holds a significant share, supported by laboratory advancements, including the launch of the University of Nairobi's Molecular Diagnostics Laboratory in June 2022.
• Clinical Biochemistry, Hematology, Diagnostic Imaging, and Others: Contribute notably to the market due to increasing adoption in routine veterinary practices.

By Animal Type:

• Companion Animals: Leading segment with 51.96% share in 2026, driven by growing pet ownership and willingness to spend on pet wellness.
• Livestock: Growing steadily due to demand for dairy products, poultry health, and food safety concerns.

By End User:

• Veterinary Reference Laboratories: Dominant with 47.41% share in 2026, reflecting the need for high-standard diagnostic practices.
• Veterinary Hospitals & Clinics: Expanding segment due to rising government hospital networks in emerging countries like India.
• Others: Include research institutes and specialized veterinary centers.

Regional Insights

North America: Market size USD 4.2 billion in 2025, projected at USD 4.17 billion by 2026, driven by high pet ownership, expenditure on pet care, and strategic diagnostic lab expansions.

Europe: Strong market due to advanced healthcare infrastructure and strategic acquisitions. The UK is projected at USD 0.28 billion, Germany at USD 0.61 billion by 2026.

Asia Pacific: Fastest-growing region with Japan at USD 0.43 billion, China at USD 0.69 billion, and India at USD 0.19 billion by 2026, fueled by zoonotic disease awareness, increasing spending on pets, and veterinary workforce development initiatives.

Latin America & MEA: Growing at a moderate rate, supported by livestock population growth and awareness campaigns for diagnostic care.

Key Players & Industry Developments

Prominent companies include IDEXX Laboratories, Inc., Zoetis Services LLC, Heska Corporation, Thermo Fisher Scientific, Virbac, Randox Laboratories, Avante Animal Health, VCA Animal Hospitals, and Shenzhen Mindray Bio-Medical Electronics.

Recent Developments:

• January 2024: Center Point Bio-Tech launched AlphaION, a new diagnostic system in the U.S.
• November 2023: Antech opened a veterinary diagnostics lab in the U.K.
• February 2023: Virbac established an R&D and diagnostic center for aquaculture in Vietnam.
• June 2023: Boule Diagnostics launched H50V, a 5-part veterinary solution in Europe.

Conclusion

The global veterinary diagnostics market is projected to grow from USD 8.78 billion in 2025 to USD 9.72 billion in 2026, reaching USD 21.59 billion by 2034 at a CAGR of 10.50%. The market is driven by increasing pet ownership, rising prevalence of zoonotic and livestock diseases, advanced diagnostic technologies, and government support initiatives. Challenges such as shortage of skilled veterinary professionals and limited access to high-end diagnostics may restrain growth. Nevertheless, ongoing technological innovations, rising pet care expenditure, and strategic expansions by key players are expected to ensure robust growth and enhance global veterinary healthcare outcomes.

Segmentation By Product Type

• Instruments
• Reagents & Consumables

By Technique

• Hematology
• Immunodiagnostics
• Molecular Diagnostics
• Diagnostic Imaging
• Clinical Biochemistry
• Others

By Animal Type

• Livestock
• Companion

By End User

• Veterinary Hospitals & Clinics
• Veterinary Reference Laboratories
• Others

By Region

• North America (By Product Type, By Technique, By Animal Type, By End User, and By Country)
  • U.S.
  • Canada
• Europe (By Product Type, By Technique, By Animal Type, By End User, and By Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, By Technique, By Animal Type, By End User, and By Country/Sub-Region)
  • China
  • India
  • Japan
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, By Technique, By Animal Type, By End User, and By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Technique, By Animal Type, By End User, and By Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Pet Ownership Statistics, By Key Countries, 2024
• 4.2. Prevalence of Key Veterinary Diseases, By Key Countries/ Regions
• 4.3. Overview of Pet Insurance, By Key Countries/ Regions
• 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships)
• 4.5. Technological Advancements in Veterinary Diagnostics
• 4.6. Impact of Covid-19 on the Market

5. Global Veterinary Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Instruments
  • 5.1.2. Reagents & Consumables
• 5.2. Market Analysis, Insights and Forecast - By Technique
  • 5.2.1. Hematology
  • 5.2.2. Immunodiagnostics
  • 5.2.3. Molecular Diagnostics
  • 5.2.4. Diagnostic Imaging
  • 5.2.5. Clinical Biochemistry
  • 5.2.6. Others
• 5.3. Market Analysis, Insights and Forecast - By Animal Type
  • 5.3.1. Livestock
  • 5.3.2. Companion
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Veterinary Hospitals & Clinics
  • 5.4.2. Veterinary Reference Laboratories
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Veterinary Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Instruments
  • 6.1.2. Reagents & Consumables
• 6.2. Market Analysis, Insights and Forecast - By Technique
  • 6.2.1. Hematology
  • 6.2.2. Immunodiagnostics
  • 6.2.3. Molecular Diagnostics
  • 6.2.4. Diagnostic Imaging
  • 6.2.5. Clinical Biochemistry
  • 6.2.6. Others
• 6.3. Market Analysis, Insights and Forecast - By Animal Type
  • 6.3.1. Livestock
  • 6.3.2. Companion
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Veterinary Hospitals & Clinics
  • 6.4.2. Veterinary Reference Laboratories
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Veterinary Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Instruments
  • 7.1.2. Reagents & Consumables
• 7.2. Market Analysis, Insights and Forecast - By Technique
  • 7.2.1. Hematology
  • 7.2.2. Immunodiagnostics
  • 7.2.3. Molecular Diagnostics
  • 7.2.4. Diagnostic Imaging
  • 7.2.5. Clinical Biochemistry
  • 7.2.6. Others
• 7.3. Market Analysis, Insights and Forecast - By Animal Type
  • 7.3.1. Livestock
  • 7.3.2. Companion
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Veterinary Hospitals & Clinics
  • 7.4.2. Veterinary Reference Laboratories
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.5.1. Germany
  • 7.5.2. U.K.
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Veterinary Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Instruments
  • 8.1.2. Reagents & Consumables
• 8.2. Market Analysis, Insights and Forecast - By Technique
  • 8.2.1. Hematology
  • 8.2.2. Immunodiagnostics
  • 8.2.3. Molecular Diagnostics
  • 8.2.4. Diagnostic Imaging
  • 8.2.5. Clinical Biochemistry
  • 8.2.6. Others
• 8.3. Market Analysis, Insights and Forecast - By Animal Type
  • 8.3.1. Livestock
  • 8.3.2. Companion
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Veterinary Hospitals & Clinics
  • 8.4.2. Veterinary Reference Laboratories
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.5.1. China
  • 8.5.2. India
  • 8.5.3. Japan
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Veterinary Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Instruments
  • 9.1.2. Reagents & Consumables
• 9.2. Market Analysis, Insights and Forecast - By Technique
  • 9.2.1. Hematology
  • 9.2.2. Immunodiagnostics
  • 9.2.3. Molecular Diagnostics
  • 9.2.4. Diagnostic Imaging
  • 9.2.5. Clinical Biochemistry
  • 9.2.6. Others
• 9.3. Market Analysis, Insights and Forecast - By Animal Type
  • 9.3.1. Livestock
  • 9.3.2. Companion
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Veterinary Hospitals & Clinics
  • 9.4.2. Veterinary Reference Laboratories
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Veterinary Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Instruments
  • 10.1.2. Reagents & Consumables
• 10.2. Market Analysis, Insights and Forecast - By Technique
  • 10.2.1. Hematology
  • 10.2.2. Immunodiagnostics
  • 10.2.3. Molecular Diagnostics
  • 10.2.4. Diagnostic Imaging
  • 10.2.5. Clinical Biochemistry
  • 10.2.6. Others
• 10.3. Market Analysis, Insights and Forecast - By Animal Type
  • 10.3.1. Livestock
  • 10.3.2. Companion
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Veterinary Hospitals & Clinics
  • 10.4.2. Veterinary Reference Laboratories
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles
  • 11.2.1. IDEXX Laboratories, Inc.
    • 11.2.1.1. Overview
    • 11.2.1.2. Product
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. financials (Based on Availability)
  • 11.2.2. Zoetis Services LLC
    • 11.2.2.1. Overview
    • 11.2.2.2. Product
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. financials (Based on Availability)
  • 11.2.3. Heska Corporation
    • 11.2.3.1. Overview
    • 11.2.3.2. Product
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. financials (Based on Availability)
  • 11.2.4. Thermo Fisher Scientific Inc.
    • 11.2.4.1. Overview
    • 11.2.4.2. Product
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. financials (Based on Availability)
  • 11.2.5. Avante Animal Health
    • 11.2.5.1. Overview
    • 11.2.5.2. Product
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. financials (Based on Availability)
  • 11.2.6. Virbac
    • 11.2.6.1. Overview
    • 11.2.6.2. Product
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. financials (Based on Availability)
  • 11.2.7. Randox Laboratories Ltd.
    • 11.2.7.1. Overview
    • 11.2.7.2. Product
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. financials (Based on Availability)
  • 11.2.8. VCA Animal Hospitals (Mars, Incorporated)
    • 11.2.8.1. Overview
    • 11.2.8.2. Product
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. financials (Based on Availability)
  • 11.2.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
    • 11.2.9.1. Overview
    • 11.2.9.2. Product
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. financials (Based on Availability)